HIV-1 integrase inhibitors (Cotinga Pharmaceuticals)

N/A

Report date: 2025/03/20 15:47:23
NME

Base Information

Drug NameHIV-1 integrase inhibitors (Cotinga Pharmaceuticals)
Drug Alias NameHIV-1 integrase inhibitors (Critical Outcome Technologies)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHIV integrase inhibitors
TargetsHIV integrase
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCotinga Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCotinga Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A